Controlled Clinical TrialtaVNSn = 41

A distinct biomarker of continuous transcutaneous vagus nerve stimulation treatment in major depressive disorder

Tu Y, Fang J, Cao J, Wang Z, Park J, Jorgenson K, Lang C, Liu J, Zhang G, Zhao Y, et al.

Brain Stimulation · 2018

Key finding

In mild-to-moderate MDD, treatment-induced insula connectivity changes after real versus sham taVNS correlated with and predicted improvement in 24-item HAMD scores.

Condition
Depression
Stimulation
taVNS
Evidence tier
Controlled Clinical Trial
Participants
41
View on DOI

Cite this study

Tu, Y., Fang, J., Cao, J., Wang, Z., Park, J., Jorgenson, K., Lang, C., Liu, J., Zhang, G., Zhao, Y., Zhu, B., Rong, P., & Kong, J. (2018). A distinct biomarker of continuous transcutaneous vagus nerve stimulation treatment in major depressive disorder. Brain Stimulation, 11(3), 501-508. https://doi.org/10.1016/j.brs.2018.01.006

Related studies in Depression

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.